Profil
Stephen S.
Yoder is currently Co-Managing Director at Pieris Pharmaceuticals GmbH.
Former positions include President & Chief Executive Officer at Marika, Inc., President, Chief Executive Officer & Director at Pieris AG, President, Chief Executive Officer & Director at Pieris Pharmaceuticals, Inc. from 2014 to 2024, Chief Executive Officer at Palvella Therapeutics, Inc., and General Counsel at MorphoSys AG from 1999 to 2010.
Education includes undergraduate studies at Grove City College and graduate studies at George Washington University Law School.
Aktiva positioner av Stephen Yoder
| Företag | Position | Start |
|---|---|---|
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Verkställande Direktör | - |
Tidigare kända positioner av Stephen Yoder
| Företag | Position | Slut |
|---|---|---|
| PIERIS PHARMACEUTICALS | Verkställande Direktör | 2024-12-13 |
| MORPHOSYS AG | Generell Rådgivare | - |
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Verkställande Direktör | - |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Verkställande Direktör | - |
Stephen Yoders utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Commercial Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Grove City College
Grove City College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
George Washington University Law School
George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















